Cervavac was developed by Serum Institute Of India (SII) in collaboration with central government’s department of ...

Updated phase 3 data support pembrolizumab plus concurrent chemoradiotherapy as a standard of care for patients with high-risk, locally advanced cervical cancer, according to Linda Duska, MD.

Schistosoma haematobium can trigger cancer-related gene activity in the cervix, increasing the risk for cervical cancer, according to data presented at the ESCMID Global meeting.

Denmark aims to eradicate cervical cancer by 2040 thanks to a national HPV vaccination campaign and screening program, the ...

Cervical cancer constitutes a formidable health challenge imperiling the well-being and lives of women globally, particularly in underdeveloped nations. The survival rates among patients diagnosed ...